Endurant Capital Management LP / BMY
Endurant Capital Management LP’s Bristol-Myers Squibb Co Position
Does Endurant Capital Management LP own Bristol-Myers Squibb Co (BMY)? Not currently — the last reported position was 158.7K shares worth $11M in Q3 2022; the fund’s latest 13F (Q1 2024) no longer reports it.
Position Value
$11M
Q3 2022
Shares
158.7K
% of Portfolio
+3.67%
Quarters Held
14
position exited
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2022 | 158.7K | $11M | +3.67% |
| Q1 2022 | 194.7K | $14M | +3.75% |
| Q3 2021 | 211.8K | $13M | +2.85% |
| Q2 2021 | 101.1K | $7M | +1.86% |
| Q1 2021 | 233.9K | $15M | +3.85% |
| Q4 2020 | 244.1K | $15M | +5.46% |
| Q3 2020 | 390.2K | $24M | +6.96% |
| Q2 2020 | 36.1K | $2M | +0.12% |
| Q1 2020 | 136.9K | $8M | +3.46% |
| Q4 2019 | 401.4K | $26M | +8.12% |
| Q3 2019 | 291.9K | $15M | +5.31% |
| Q2 2019 | 86.3K | $4M | +1.54% |
| Q1 2019 | 291.3K | $14M | +5.49% |
| Q4 2018 | 49.3K | $3M | +1.36% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Endurant Capital Management LP’s full portfolio or all institutional holders of BMY.